Dental pulp is the soft living tissue inside a tooth that contains mesenchymal stem cells (MSCs). While MSCs from dental pulp stem cells are only being used only in laboratory settings right now, there are now a handful of forward-thinking companies that offer dental stem cell storage services to preserve the cells for future regenerative use.
The dental pulp storage market is still relatively small, because of the early stage of research concerning the use of dental pulp stem cells in humans. However, it is rapidly expanding on a global basis, with 1-2 new dental storage providers are entering the market every month, based on a trailing 12-month history (January to December, 2015).
BioEden began offering tooth stem cell storage as early as 2006, making it one of the earliest known providers of dental stem cell storage. Over the past decade, the company has continued to be one of the most dominant competitors in this space, controlling an estimated 45% of current market share within the dental stem cell storage market. Click here to learn more about the dental stem cell banking market or to read our recent interview with BioEden’s CEO, Tony Veverka.
With permission from BioEden, the company’s press release announcing 275% grow in demand for its services and expansion into the Netherlands is included below.
PRESS RELEASE: BioEden the world’s first tooth stem cell bank announce further expansion into the Netherlands
More and more parents are choosing to cyropreserve the stem cells from their children’s naturally shed baby teeth as BioEden announce further expansion and ‘go Dutch’.
Stem cell therapy and research shows no sign of slowing down as BioEden announce a record breaking 275% demand for their service, and extend their reach to Belgium and Holland.
BioEden was originally founded in 2006 in Austin Texas and was the first specialist stem cell bank, today widely acknowledged as the market leader. The company stores stem cells from the baby teeth of children, and emphasises that there is no need for the teeth to be extracted, as they fall out naturally.
The BioEden method of stem cell isolation and storage of baby teeth is unique and holds the only issued patent. With members in more than 60 countries and laboratories in Asia, the United States and the United Kingdom BioEden continues to lead and develop their proposition, which could bring stem cell banking to the masses.
Group CEO Tony Veverka says ‘The BioEden technique can offer many advantages over the known stem cell storage from umbilical cord blood. Moreover, the method is simpler an more affordable.
We are delighted to be able to provide our potentially life saving services to the people of Belgium and Holland.
Want to get future stem cell industry updates? Join below and we’ll keep you in the loop.
Or, check out our global strategic reports for the stem cell and cord blood industry.